Published on : Jun 08, 2017
Albany, New York, June 08, 2017: The application of HSCT for various chronic diseases such as lymphoproliferative disorders, leukemia, and various non-malignant disorders has resulted in the industry growth of the hematopoietic stem cell transplantation (HSCT) market. To elaborate further, Market Research Hub (MRH) has recently added a report titled as “Hematopoietic Stem Cell Transplantation (HSCT) Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024” to its vast database. According to the analysis, the market is estimated to increase at a CAGR of 12.80% from 2017 to 2025, rising at a fast pace.
The researched study commences with the market overview section of the report which explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the global hematopoietic stem cell transplantation (HSCT) market, and could influence the market in the near future. The main market drivers are rising prevalence of hematological disorders, increase in success rates of transplantation, favorable reimbursement policies & fervent funding, increasing patient awareness and health care expenditure and increased aging population. Restraints of the market analyzed in the report are insufficient allogeneic donors, potential complications and side effects of HSC transplant, the high cost of transplants and drug development that may impact HSC transplant rates.
Further, the HSCT market is segmented by transplant type, by disease indication, by application, and by region. The transplant type segment of HSCT market is divided into autologous transplant and allogeneic transplant, the allogeneic transplant is further segmented into family related and unrelated transplant. The disease indication has classified the market into, leukemia, lymphoproliferative disorders, and non-malignant disorders. The application of the hematopoietic stem cell transplantation (HSCT) market has been segregated as peripheral blood stem cells transplant (PBSCT), bone marrow transplant (BMT), and cord blood transplant (CBT). On the geographical scenario, the market of HSCT is analyzed for regions comprising North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. Among these, Europe and North America has been leading the global market since several years and Europe has been further estimated to hold the dominant position over the next few years as well.
Click here to get more info with TOC in a PDF Format : http://www.marketresearchhub.com/enquiry.php?type=S&repid=1109478
Finally, the report provides the competition landscape by various attributes that comprise company details, business overview, financial overview, strategic overview and SWOT analysis. Major players profiled in this report include Escape Therapeutics Inc., Regen Biopharma Inc., Lonza Group Ltd., and Pluristem Therapeutics
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
For Enquiries, Call :
+1-800-998-4852US Toll Free
Email : email@example.com